<DOC>
	<DOCNO>NCT02182154</DOCNO>
	<brief_summary>To assess metabolic profile , obtain mass balance oral administration , determine concentration [ 14C ] -radioactivity blood cell , plasma , urine faeces , determine BIBF 1120 BIBF 1202 concentration plasma , urine , faeces , feasible , determine protein bind [ 14C ] -radioactivity , determine pharmacokinetics BIBF 1120 , BIBF 1202 total radioactivity single oral administration [ 14C ] -BIBF 1120 healthy volunteer</brief_summary>
	<brief_title>Metabolism Pharmacokinetics 14C-BIBF 1120 Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Nintedanib</mesh_term>
	<criteria>1 . Healthy male subject determine result screen 2 . Signed write informed consent accordance GCP local legislation 3 . Age ≥21 ≤55 year 4 . Body Mass Index ≥18.5 kg/m2 ≤29.9 kg/m2 1 . Any finding medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance 2 . History current gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunologic , hormonal disorder 3 . History major surgery within last four week participation study bone fracture within last two month 4 . History orthostatic hypotension , faint spell blackouts 5 . Diseases central nervous system ( epilepsy ) psychiatric disorder 6 . Chronic relevant acute infection 7 . History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator 8 . History bleed disorder include prolonged habitual bleeding , haematologic disease cerebral bleeding ( e.g . car accident ) commotio cerebri 9 . Intake drug long halflife ( &gt; 24 hour ) within 1 month prior administration 10 . Planned use drug might influence result trial within 10 day prior administration trial 11 . Participation another trial investigational drug within 2 month prior administration trial 12 . Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) inability refrain smoke study day 13 . Alcohol abuse ( &gt; 60 g/day ) 14 . Drug abuse 15 . Blood donation within 1 month prior administration trial 16 . Excessive physical activity within 5 day prior administration trial 17 . Any laboratory value outside reference range , unless consider lack clinical reference 18 . Female gender 19 . Male subject must agree minimize risk female partner become pregnant dose day 3 month completion study . Acceptable method contraception male volunteer include vasectomy less 3 month prior dose , barrier contraception medically accept contraceptive method . For female partner male volunteer , acceptable method contraception include intrauterine device , tubal ligation , hormonal contraceptive since least two month diaphragm spermicide</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>